Developing new methods for targeted chemical modifications of proteins and drugs
Peptide-Conjugated Palladium Oxidative Addition Complexes for Site-Selective Arylation Chemistry
This study is exploring new ways to change proteins in a targeted way using special chemicals, which could help make medicines work better and lead to new treatments for various health conditions.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10912476 on NIH RePORTER |
What this research studies
This research focuses on creating innovative chemical methods to modify biomolecules, particularly proteins, in a precise manner. By using palladium complexes, the team aims to achieve site-selective modifications that can enhance the effectiveness of drugs and biomaterials. The approach involves attaching peptide sequences to these complexes, allowing for targeted interactions with specific proteins. This could lead to advancements in drug development and the creation of new therapeutic agents.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals with conditions that could benefit from advanced drug therapies or biomaterials.
Not a fit: Patients who are not seeking new treatment options or those with conditions that do not involve protein modifications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and targeted therapies for various diseases.
How similar studies have performed: Previous research has shown promise in similar chemical modification techniques, indicating potential for success in this novel approach.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Kutateladze, Dennis a. — Massachusetts Institute of Technology
- Study coordinator: Kutateladze, Dennis a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.